Researchers detected cancer-linked genetic mutations in blood samples taken over three years before diagnosis. In a ...

A highly transmissible new COVID-19 variant called NB.1.8.1, aka "Nimbus," is spreading in the United States, CDC data show.

Human papillomavirus (HPV) can drive tumor development in some rare sinonasal squamous cell carcinomas (SNSCCs), according to ...

AstraZeneca's camizestrant and Pfizer's vepdegestrant extended progression-free survival in trials in advanced ESR1-mutated breast cancer.

A NEW triple threat drug combination could hold aggressive breast cancer at bay for an extra year, a trial found. Adding the ...

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced breast cancer, compared with palbociclib and ...

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced breast cancer, compared with palbociclib and fulve ...

“Itovebi exemplifies our continued commitment to improve survival rates for people with this common PIK3CA mutation ... right away if you develop symptoms of high blood sugar, including ...

Liquid biopsy preferred for ESR1 mutation detection due to subclonal nature (15%-20% better detection) PIK3CA mutations are clonal and detectable in the initial tissue biopsy Prior CDK4/6 inhibitor ...

They are rare diseases that are caused mostly by somatic mutations and can present with variable symptoms based upon the size and location ... characterized by tissue overgrowth, such as the ...

Mutations in this gene can cause ... Each has its own set of symptoms, although some may overlap. Specific PIK3CA gene variants occur only within the cells of the affected areas of the body.